StockNews.AI
TKNO
StockNews.AI
180 days

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

1. Q4 and fiscal year results will be reported. Announcement set for March 4, 2025. 2. Webcast and conference call available. Registration required for unique PIN and dial-in. 3. Teknova produces critical reagents for life sciences. Company details manufacturing capabilities.

4m saved
Insight
Article

FAQ

Why Neutral?

Earnings reports typically cause short-term volatility if results deviate from expectations. Historical results announcements have led to immediate price adjustments, though routine reporting is expected and often priced in.

How important is it?

The news is directly relevant to TKNO as an upcoming earnings report. While the event is expected, it can trigger short-term volatility based on performance surprises.

Why Short Term?

Earnings announcements usually drive immediate market reactions. Past earnings releases have influenced short-term trading activity even if long-term fundamentals remain unchanged.

Related Companies

February 20, 2025 16:05 ET  | Source: Alpha Teknova, Inc. HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market. Teknova will host a webcast and conference call on Tuesday, March 4, 2025, beginning at 5 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event. About TeknovaTeknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies. Investor ContactMatt LowellChief Financial Officermatt.lowell@teknova.com+1 831-637-1100  Media ContactJennifer HenrySenior Vice President, Marketingjenn.henry@teknova.com+1 831-313-1259

Related News